This paper is only available as a PDF. To read, Please Download here.
Background
Stereotactic breast biopsy has been developed as a less invasive means of performing
biopsy for mammographic abnormalities. Methods: From July 1994 through June 1995,103
women with mammographic abnormalities requiring biopsy were prospectively evaluated.
Results
Fifty-one women had open biopsy, and 52 women had Stereotactic biopsy. The average
age in both groups was 60 years. Pathology revealed alignancy in 12% of Stereotactic
biopsies and 13% of open biopsies. Complications occurred in 6% of the open biopsies
and 4% of the Stereotactic biopsies and were limited to hematomas or seromas. The
average cost was $2400 for open biopsy and $650 for Stereotactic biopsy (P < 0.01). One hundred and one patients returned for a follow-up mammogram within 6
months, and 1 patient in each group required a second biopsy, which revealed benign
pathology. Patient Satisfaction Survey revealed no significant differences in patient
satisfaction between the two types of procedures.
Conclusion
There were no differences between open and Stereotactic biopsies in regards to diagnostic
accuracy, complications, or patient satisfaction. A significant difference was noted
in charges during the time frame of our study.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Current results in the breast cancer screening randomized trial: the Health Insurance Plan of Greater New York Study.in: Day NE Miller AB Screening for Breast Cancer. Hans Huber, Toronto1988
- Hooked-wire-directed breast biopsy and overpenetrated mammography.Cancer. 1987; 59: 715-722
- Nonpalpable breast lesions: accuracy of prebiopsy mammographic diagnosis.Radiology. 1990; 165: 323-326
- Surgery for nonpalpable breast lesions.Arch Surg. 1990; 125: 399-402
- Cytologic diagnosis of occult breast lesions using stereotaxic needle aspirations. A preliminary report.Arch Surg. 1987; 122: 1343-1346
- Stereotactic fine-needle aspiration for cytologic diagnosis of nonpalpable breast lesions.Am J Roentgenol. 1990; 154: 1191-1195
- Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques.Am J Roentgenol. 1994; 162: 815-820
- Percutaneous largecore breast biopsy: a multi-institutional study.Radiology. 1994; 193: 359-364
- Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results.Radiology. 1993; 188: 453-455
- Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion.Radiology. 1995; 194: 379-381
- Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy.Am J Roentgenol. 1995; 164: 1111-1113
- Stereotaxic largecore needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia.Radiology. 1994; 193: 91-95
- Impact of stereotaxic core breast biopsy on cost of diagnosis.Radiology. 1995; 195: 633-637
Article info
Footnotes
**Presented at the 48th Annual Meeting of the Southwestern Surgical Congress, Scottsdale, Arizona, April 28–May 1, 1996.
Identification
Copyright
© 1996 Excerpta Medica, Inc. All rights reserved. Published by Elsevier Inc.
